Health Care Supplies

Cuprina

Cuprina released FY2025 Q3 earnings on April 27 (EST), actual revenue USD 10.42 K, actual EPS USD -0.0487

Cuprina released FY2025 annual earnings on April 27 (EST), actual revenue USD 38.49 K, actual EPS USD -0.1761

Cuprina released FY2025 Q4 earnings on April 27 (EST), actual revenue USD 10.46 K, actual EPS USD -0.0489

Cuprina released FY2025 9 Months earnings on April 27 (EST), actual revenue USD 28.01 K, actual EPS USD -0.1262

Cuprina released FY2025 Q2 earnings on December 9 (EST), actual revenue USD 9.016 K, actual EPS USD -0.0397

Cuprina released FY2025 Q1 earnings on December 9, 2025 (EST), actual revenue USD 8.578 K, actual EPS USD -0.0377

Cuprina released FY2025 Semi-Annual earnings on December 9, 2025 (EST), actual revenue USD 17.59 K, actual EPS USD -0.0775

Cuprina Holdings Conducts Collagen Peptide Clinical Study

Cuprina MENA Completes Lab in Saudi Arabia and Secures Exclusive Sales Rights

Cuprina released FY2024 9 Months earnings on May 14 (EST), actual revenue USD 33.18 K, actual EPS USD -0.0475

Cuprina released FY2024 Q3 earnings on May 14 (EST), actual revenue USD 2.857 K, actual EPS USD -0.0185

Cuprina released FY2024 Annual Earnings on May 14 EST, with actual revenue of USD 36.14 K and EPS of USD -0.0648

Cuprina released FY2024 Q4 earnings on May 14, 2025 (EST) with actual revenue of USD 2.689 K and EPS of USD -0.0174

Cuprina Holdings and Ferti-Craft Complete IVF Media Production Facility Construction

CUPR.US released FY2024 semi-annual earnings on December 6 (BJT), with actual revenue of USD 30.32 K and EPS of USD -0.0289

CUPR.US released FY2023 semi-annual earnings on December 6, BJT, with actual revenue of USD 33.3 K and EPS of USD -0.0187

CUPR.US released FY2023 Q1 earnings on December 6, 2024 (BJT) with actual revenue of USD 16.8K and EPS of USD -0.0094

Cuprina Holdings (Cayman) Limited released FY2024 Q1 earnings on December 6, 2024 (EST), with actual revenue of USD 15.2 K and EPS of USD -0.0144

Cuprina released FY2024 Q2 earnings on December 6, 2024 (EST), with actual revenue of USD 15.12 K and EPS of USD -0.0144

Cuprina Holdings (Cayman) Limited released FY2023 Q2 earnings on December 6, 2024 (EST), with actual revenue of USD 16.48 K and EPS of USD -0.0092

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

CUPR

Rosen Law Firm is investigating potential securities claims for shareholders of Cuprina Holdings (Cayman) Ltd. (NASDAQ: CUPR) due to allegations of misleading business information. Investors who purchased Cuprina securities may be eligible for compensation through a class action lawsuit, with no upfront costs. The firm emphasizes the importance of selecting experienced legal counsel for such cases. Rosen Law Firm has a strong track record in securities class actions, having secured significant settlements for investors.

MorningStar

Rosen Law Firm Encourages Cuprina Holdings (Cayman) Ltd. Investors to Inquire About Securities Class Action Investigation – CUPR

TJGC

Rosen Law Firm is investigating potential securities claims for TJGC Group Limited (NASDAQ: TJGC) shareholders due to allegations of misleading business information. Investors who purchased TJGC securities may be eligible for compensation through a class action without upfront costs. Interested parties can contact Phillip Kim, Esq. for more information. The firm has a strong track record in securities class actions, having secured significant settlements for investors.

Rosen Law Firm Encourages TJGC Group Limited Investors to Inquire About Securities Class Action Investigation – TJGC

ARKG

QNCX

SBIO

IBBQ

KPRX

In Wednesday's intraday session, several health care stocks experienced significant movements. Gainers included Quince Therapeutics (up 31.6% to $0.21), Cue Biopharma (up 28.26% to $0.24), and Kiora Pharmaceuticals (up 24.07% to $2.68). On the downside, Cuprina Holdings saw a decline of 28.1% to $0.43, while LeonaBio fell 18.33% to $9.54. Other notable losers included SILO Pharma (down 17.04% to $0.44) and NeuroOne Medical Tech (down 12.02% to $0.73).

benzinga_article

iShares Biotechnology ETF

Ark Genomic Revolution ETF

Quince Therapeutics

Health Care Select Sector SPDR

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

NeuroOne Medical Tech

Kiora Pharmaceuticals

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

LeonaBio

12 Health Care Stocks Moving In Wednesday's Intraday Session

SILO

LABU

In Wednesday's pre-market session, Quince Therapeutics (NASDAQ:QNCX) saw a significant gain of 98.6%, reaching $0.32, with a market cap of $9.0 million. Other gainers included Cypherpunk Technologies (NASDAQ:CYPH) up 16.59% to $0.85, and MapLight Therapeutics (NASDAQ:MPLT) up 15.99% to $28.0. Conversely, Cuprina Holdings (Cayman) (NASDAQ:CUPR) experienced the largest decline, falling 28.2% to $0.43. Talphera (NASDAQ:TLPH) and SILO Pharma (NASDAQ:SILO) also saw losses of 11.59% and 10.98%, respectively.

iShares US Pharma

Silo Pharma

SPDR S&P Health Equip

VG Health

iShares US Medical Devices

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

MapLight Therapeutics

Talphera

Direxion S&P Biotech Bull 3X

9 Health Care Stocks Moving In Wednesday's Pre-Market Session

PFSA

ADTX

In Tuesday's pre-market session, SILO Pharma saw a significant gain of 74.4%, reaching $0.62, while Advanced Biomed rose by 66.96% to $7.38. Other gainers included Cuprina Holdings (+27.66%), Kiora Pharmaceuticals (+17.32%), Organogenesis Holdings (+16.96%), and Pomdoctor (+12.62%). Conversely, Profusa experienced the largest decline at 18.4%, followed by Revelation Biosciences (-12.94%), GRI Bio (-12.22%), SIGA Technologies (-10.01%), and Aditxt (-9.6%).

Profusa

SPDR S&P Biotech

Revelation Biosciences

Organogenesis

GRI Bio

Siga Tech

Aditxt

Pomdoctor

Advanced Biomed

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

MIGI

BGDE

Cuprina pre-market up 104.61%; Mawson Infrastructure pre-market up 25.79%; Advanced Biomed pre-market up 69.46%; Huachen AI Parking Management Tech pre-market up 59.10%; Silo Pharma pre-market up 48.93%

Price Alert

Big Digital Energy

Pre-market hot trades in US stocks: Cuprina up 104.61% pre-market; Mawson Infrastructure up 25.79% pre-market

AIFF

In Monday's pre-market session, several health care stocks saw significant movement. Milestone Scientific (MLSS) shares surged 34.4% to $0.33, while BGM Group (BGM) rose 30.44% to $0.78. Zhengye Biotechnology (ZYBT) increased by 26.76% to $0.9, and Firefly Neuroscience (AIFF) gained 23.52% to $1.89. Apogee Therapeutics (APGE) and Insmed (INSM) also saw increases of 13.56% and 10.25%, respectively. Conversely, Valneva (VALN) dropped 36.8% to $6.52, followed by Impact BioMedical (IBO) down 23.04% to $0.6. Other notable losers included Onconetix (ONCO), Anika Therapeutics (ANIK), NeuroPace (NPCE), and CDT Equity (CDT).

Invesco Dorsey Wright Healthcare Momentum ETF

Firefly Neuroscience

Milestone Scientific

Apogee Therapeutic

Insmed

Zhengye Biotechnology

Onconetix

12 Health Care Stocks Moving In Monday's Pre-Market Session

In Thursday's pre-market session, Serina Therapeutics (AMEX:SER) saw a significant gain of 36.7%, reaching $1.75, while Addex Therapeutics (NASDAQ:ADXN) rose by 29.49% to $7.64. Other gainers included Cuprina Holdings (NASDAQ:CUPR) up 16.54% to $0.4, and Spectral AI (NASDAQ:MDAI) up 13.31% to $1.36. Conversely, Reviva Pharmaceuticals (NASDAQ:RVPH) experienced a sharp decline of 47.6% to $0.98, followed by Quince Therapeutics (NASDAQ:QNCX) down 17.94% to $0.08. Agilon Health (NYSE:AGL) fell 15.27% to $0.5, and AIM ImmunoTech (AMEX:AIM) dropped 11.28% to $0.91.

Cuprina(CUPR.US)